Monoclonal antibody therapy for Junin virus infection (Q36831453)

16 August 2017

Monoclonal antibody therapy for Junin virus infection (English)

1 reference

16 August 2017

Charles Goodman

7

0 references

Anna N. Honko

object named as

Anna N Honko

16

0 references

Herta Steinkellner

object named as

Herta Steinkellner

15

0 references

Thomas W Geisbert

23

object named as

Thomas W Geisbert

1 reference

16 August 2017

2

Joan B Geisbert

1 reference

16 August 2017

4

Karla A Fenton

1 reference

16 August 2017

12

Kevin J Whaley

1 reference

16 August 2017

1

Larry Zeitlin

1 reference

16 August 2017

9

Andrew Hiatt

1 reference

16 August 2017

6

Natasha Bohorova

1 reference

16 August 2017

5

Ognian Bohorov

1 reference

16 August 2017

Daniel J Deer

3

1 reference

16 August 2017

Do Kim

8

1 reference

16 August 2017

Michael H Pauly

10

1 reference

16 August 2017

Jesus Velasco

11

1 reference

16 August 2017

Friedrich Altmann

13

1 reference

16 August 2017

Clemens Gruber

14

1 reference

16 August 2017

Ana I Kuehne

17

1 reference

16 August 2017

M Javad Aman

18

1 reference

16 August 2017

Sara Sahandi

19

1 reference

16 August 2017

Sven Enterlein

20

1 reference

16 August 2017

Xiaoguo Zhan

21

1 reference

16 August 2017

Delia Enria

22

1 reference

16 August 2017

language of work or name

English

0 references

publication date

4 April 2016

1 reference

Proceedings of the National Academy of Sciences of the United States of America

16 August 2017

1 reference

16 August 2017

113

1 reference

16 August 2017

16

1 reference

16 August 2017

4458-4463

1 reference

The role of Fc-FcγR interactions in IgG-mediated microbial neutralization

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Therapeutic strategies to improve drug delivery across the blood-brain barrier

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Junín virus pathogenesis and virus replication

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Effect of ribavirin on junin virus infection in guinea pigs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Industrialization of mAb production technology: the bioprocessing industry at a crossroads

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Treatment of Argentine hemorrhagic fever

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Protective effect of a low-dose of cyclophosphamide in experimental infection of guinea pigs with Junin virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Experimental biology and pathogenesis of Junin virus infection in animals and man

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Dynamics of brain-derived proteins in cerebrospinal fluid

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843420

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073/PNAS.1600996113

21 January 2018

Identifiers

DOI

10.1073/PNAS.1600996113

1 reference

16 August 2017

0 references

1 reference

16 August 2017

PubMed publication ID

27044104

1 reference